KBC Group NV Acquires 5,177 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
KBC Group NV grew its holdings in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 136.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,970 shares of the company’s stock after buying an additional 5,177 shares during the quarter. KBC Group […]
KBC Group NV grew its holdings in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 136.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,970 shares of the company’s stock after buying an additional 5,177 shares during the quarter. KBC Group […]
